Based on TCGA data, we found that GPC1 expression was upregulated in multiple cancers, including breast cancer, cervical cancer, bile duct cancer, colon cancer, glioblastoma, head and neck cancer, kidney papillary cell carcinoma, lung adenocarcinoma, and pancreatic cancer (Figure 1(a)). The gene discussed is GPC1; the disease is head and neck cancer.